Here are four insights:
1. Conventus Orthopaedics specializes in developing devices and technology to treat fractured arm and leg bone joints.
2. With the loan closing Dec. 22, 2017, Conventus Orthopaedics plans to use the funds to continue commercial development of its fracture management system, Conventus Cage.
3. The Conventus Cage is designed for less invasive bone and joint treatments and provides patients with a quicker recovery time.
4. Other investors in Conventus Orthopaedics include Deerfield Management and Sightline Partners.
More articles on devices and implants:
Global arthroscopic devices market to exceed $1.7B by 2022: 6 notes
OrthoPediatrics launches 24th surgical system: 3 things to know
Arthrex beings headquarter expansion, to add 500+ jobs
